Pricing Log in Create free account
Saturday 17 October 2026 Export ASTH’s income statement to Excel — free account

Astrana Health, Inc.

ASTH Healthcare Medical Care Facilities

Astrana Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 56.4% from fiscal 2024. In the quarter to June 2026, revenue grew 48.5%, EPS grew 110.5%, free cash flow fell 67.7% and total debt rose 126.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

36.81 1.22 −3.21%
Market cap
$1.9B
P/E
44.3×
Fwd P/E
29.7×
Dividend yield
—
F-score
4/9
Altman Z
2.39
Beneish M
−2.19
Dividend safety
50/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 20.13%

Capital & Financial Ratios $m

Market Cap 1,890.00
Revenue 3,844.19
Net Income 39.22
Free Cash Flow 94.38
Net Debt 535.71
Current Ratio 1.23
Debt/Equity 1.11
P/E ratio 44.35 (above 35: high)
Fwd P/E 29.70
P/S ratio 0.47
P/B ratio 2.15
Past 5Y EPS Growth (14.55%) (below 0%: weak)
This Y EPS Growth 206.52% (at or above 15%: strong)
Next Y EPS Growth 40.49% (at or above 15%: strong)
Next Y revenue growth 25.15% (at or above 10%: strong)
Next 5Y EPS Growth 78.99% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.6×, against a ten-year median of 1.1×; over the ten years it ranged from 0.5× in 2026 to 5.3× in 2021.
P/E against its own 10 years 69.23%
10-year low 10-year high
P/S against its own 10 years 6.74%
10-year low 10-year high
P/B against its own 10 years 15.29%
10-year low 10-year high
EV/Sales against its own 10 years 7.69%
10-year low 10-year high
EV/FCF against its own 10 years 50.02%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2028 Powerpack
2027 Powerpack
2026 Powerpack
2025 Powerpack
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 296 288 429 401
Receivables 148 325 403 489
Inventory — — — —
Other — — — —
462 638 863 919
2023 2024 2025 Q'26
Payables 60 106 196 246
ST’ Debt 20 9 48 54
Other 19 27 24 17
219 366 615 748

Compound Annual Growth %

10y 5y 3y
Sales 26.39% 35.87% 40.62%
Cash Flow 17.99% 19.94% 11.74%
Earnings 6.98% (9.81%) (20.75%)
Book Value 24.65% 19.11% 13.38%

Revenue $m

Mar Jun Sep Dec Year
’26 965 973 — — —
’25 620 655 956 951 3,182
’24 404 486 479 665 2,035
’23 337 348 348 353 1,387
’22 263 270 317 294 1,144
’21 176 176 227 195 774
’20 165 165 180 177 687
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 68 33 — — —
’25 17 91 10 (3) 115
’24 6 23 34 (11) 52
’23 8 26 15 19 68
’22 24 9 (36) 85 82
’21 10 21 51 (12) 70
’20 (9) 22 36 (3) 46
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 64 29 — — —
’25 14 89 7 (6) 104
’24 6 20 32 (13) 44
’23 (7) 23 11 12 40
’22 7 8 (39) 84 59
’21 10 14 42 (15) 51
’20 (10) 22 36 (3) 45
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.29 0.40 — — —
’25 0.14 0.19 0.01 0.12 0.46
’24 0.31 0.40 0.33 (0.15) 0.90
’23 0.31 0.28 0.47 0.26 1.29
’22 0.31 0.25 0.56 (0.06) 1.08
’21 0.30 0.28 0.74 0.30 1.63
’20 0.11 0.19 0.45 0.27 1.01
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.4
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 1.41 5.65 13.01 13.02 9.27 18.26 26.89 27.55 31.34 20.12

Analyst estimates 2026–2028

Powerpack
High 9.00 25.00 30.00 23.26 19.68 133.23 74.01 40.81 63.20 39.97
People
People Employees 150 493 492 555 630 1,133 1,362 1,800 1,900 3,000
Revenue/emp, $m 0.00 0.72 1.06 1.01 1.09 0.68 0.84 0.77 1.07 1.06
Income, $m
Income, $m Revenue 306 356 520 561 687 774 1,144 1,387 2,035 3,182
Gross margin, % 16.72 23.26 30.54 16.56 21.53 22.97 17.43 15.50 13.34 10.73
EBT 19 50 83 26 178 78 87 90 81 40
EBT margin, % 6.16 13.95 15.89 4.61 25.97 10.05 7.57 6.48 3.97 1.24
Net income 10 46 60 18 122 46 46 58 50 24
Depreciation 18 22 23 21 20 19 18 19 30 50
Per share, $
Per share, $ Revenue 12.40 13.96 15.81 16.15 18.81 17.66 25.44 29.79 42.75 64.83
Earnings 0.41 0.90 0.33 0.41 1.04 1.69 1.09 1.30 0.91 0.46
Cash flow 0.89 2.03 0.78 0.39 1.26 1.60 1.83 1.47 1.10 2.34
Capex (0.13) (0.08) (0.04) (0.03) (0.03) (0.44) (0.51) (0.61) (0.17) (0.21)
Free cash flow 0.75 1.95 0.74 0.36 1.23 1.17 1.32 0.85 0.93 2.13
Book value 3.55 6.43 5.52 5.54 9.06 10.36 12.10 13.25 15.06 16.16
Shares, m 25 26 33 35 37 44 45 47 48 49
Valuation, ×
Valuation, × P/E 0.00 13.37 60.15 46.03 17.40 43.74 25.93 29.38 35.03 53.93
P/S 0.00 1.59 1.26 1.14 0.97 4.16 1.11 1.30 0.74 0.38
P/B 0.00 3.73 3.60 3.32 2.02 7.09 2.33 2.93 2.09 1.53
EV/Sales 0.00 1.30 1.07 1.18 0.94 4.03 1.03 1.29 0.81 0.57
EV/FCF 0.00 10.03 22.96 52.35 14.38 61.02 19.98 45.05 37.29 17.48
Cash, $m
Cash, $m Operating cash flow 22 52 25 14 46 70 82 68 52 115
Capex (3) (2) (1) (1) (1) (19) (23) (29) (8) (10)
Free cash flow 19 50 24 13 45 51 59 40 44 104
Balance, $m
Balance, $m Working capital 31 35 101 224 224 290 280 243 273 248
Total debt 0 6 14 242 241 185 205 279 435 1,039
Net debt (57) (113) (94) 22 (20) (102) (88) (17) 146 609
Shareholders’ equity 88 164 182 192 331 454 544 617 717 793
Returns, %
Returns, % ROA 6.20 10.09 2.16 2.27 4.87 8.18 4.93 6.39 3.77 1.26
ROIC 23.76 42.70 63.47 9.44 16.17 17.42 14.29 8.82 6.47 3.50
ROE 26.89 33.62 6.27 7.55 14.41 17.56 9.05 10.46 6.47 2.98
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Astrana Health, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
MD Pediatrix Medical Group, Inc. $2.3B 13.1× 11.3× +4.04% (above 0%: growing) +6.52% (above 0%: growing) −6.56% (below 0%: shrinking) 27.16% 11.67% Compare
ADUS Addus HomeCare Corporation $2.2B 20.4× 14.9× +8.01% (above 0%: growing) +24.17% (above 0%: growing) +81.74% (above 0%: growing) 32.21% 10.32% Compare
SGRY Surgery Partners, Inc. $1.9B — (loss-making) — (loss-making) +2.75% (above 0%: growing) n/m −60.63% (below 0%: shrinking) 22.41% 12.78% Compare
ASTH Astrana Health, Inc. $1.9B 44.3× 29.7× +48.52% (above 0%: growing) +110.53% (above 0%: growing) −67.74% (below 0%: shrinking) 10.70% 3.53%
ARDT Ardent Health, Inc. $1.7B 21.7× 7.7× −1.40% (below 0%: shrinking) −76.92% (below 0%: shrinking) +121.70% (above 0%: growing) 100.00% 3.44% Compare
SNDA Sonida Senior Living, Inc. $1.7B — (loss-making) — (loss-making) +122.02% (above 0%: growing) n/m −291.70% (below 0%: shrinking) 34.97% (2.63%) Compare
CMPS COMPASS Pathways PLC Sponsored ADR $1.6B — (loss-making) — — n/m −4.18% (below 0%: shrinking) — 0.00% Compare
AMN AMN Healthcare Services Inc $1.6B 15.0× 31.2× +2.29% (above 0%: growing) n/m −389.43% (below 0%: shrinking) 30.58% 4.00% Compare
AGL Agilon Health, Inc. $1.5B — (loss-making) — (loss-making) +7.15% (above 0%: growing) n/m −50.19% (below 0%: shrinking) 7.17% 0.79% Compare
Median of peers $1.7B 17.7× 13.1× +4.04% +6.52% −28.37% 30.58% 3.72%

All 55 Medical Care Facilities stocks →

Astrana Health, Inc. (ASTH) key facts

  • Strength: Astrana Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 56.4% from fiscal 2024.
  • Astrana Health, Inc. (ASTH) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, ASTH traded at $36.81, a market capitalization of $1.9 billion.
  • Return on equity was 2.98% and debt-to-equity 1.11.
  • Its Piotroski F-score is 4 out of 9 and its Altman Z-score is 2.39 (grey zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Astrana Health, Inc. (ASTH) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/ASTH · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com